The effects of indomethacin and prostaglandins E2 and F2α on canine tracheal mucus generation

Abstract
The effects of prostaglandins on respiratory smooth muscle are well known; however, their role in mucus generation has received little attention. This investigation was undertaken to study the actions of prostaglandin E2 (PGE2) and prostaglandin F (PGF) on secretion and synthesis of respiratory mucus glycoproteins. The method employed canine tracheal explants; radiochemical precursors were used in the culture media for labelling and quantitation of the secreted glycoproteins. Glycoprotein secretion was not significantly influenced by PGE2 (1×10−10 to 1×10−3 M) or PGF (1×10−8 to 1×10−4 M). However, PGF (1×10−3 M and 1×10−2 M), significantly stimulated glycoprotein secretion. The mechanism may have involved a contractile effect on myoepithelial cells of the submucosal glands. Synthesis of glycoproteins was significantly inhibited by PGF (1×10−5 M), indomethacin (1×10−6 M), and the combination PGF (1×10−5 M)/indomethacin (1×10−6 M). PGE2 (1×10−5 M) and arachidonic acid (1×10−5 M) were without effect. These data suggested that indomethacin inhibited glycoprotein synthesis by a mechanism other than an action on prostaglandin synthetase. In addition, because these agents inhibited synthesis of glycoproteins which were labeled with3H-glucosamine,35S-sulfate, and14C-serine, it appears that their action was primarily upon synthesis of the protein core.